Hartford Investment Management CO Organon & Co. Transaction History

Hartford Investment Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	SELL	$16.59 - $23.77 $6,619 - $9,484	-399 Reduced 2.23%	17,483 $303,000
Q2 2023 Jul 19, 2023	SELL	$19.27 - $24.63 $68,312 - $87,313	-3,545 Reduced 16.54%	17,882 $372,000
Q1 2023 May 09, 2023	BUY	$21.42 - $32.08 $59,611 - $89,278	2,783 Added 14.93%	21,427 $503,000
Q4 2022 Jan 20, 2023	SELL	$23.31 - $28.61 $135,943 - $166,853	-5,832 Reduced 23.83%	18,644 $521,000
Q3 2022 Nov 02, 2022	BUY	$23.4 - $34.25 $1,591 - $2,329	68 Added 0.28%	24,476 $573,000
Q2 2022 Jul 22, 2022	BUY	$31.66 - $38.9 $22,446 - $27,580	709 Added 2.99%	24,408 $824,000
Q1 2022 Apr 20, 2022	SELL	$30.45 - $39.36 $56,119 - $72,540	-1,843 Reduced 7.22%	23,699 $828,000
Q4 2021 Feb 02, 2022	BUY	$28.67 - $37.13 $54,300 - $70,324	1,894 Added 8.01%	25,542 $778,000
Q3 2021 Nov 01, 2021	BUY	$28.63 - $35.64 $677,042 - $842,814	23,648 New	23,648 $775,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Hartford Investment Management CO with notifications on news.